111 related articles for article (PubMed ID: 8294552)
1. Antibody of patients with Guillain-Barré syndrome mediates complement-dependent cytolysis of rat Schwann cells: susceptibility to cytolysis reflects Schwann cell phenotype.
Sawant-Mane S; Estep A; Koski CL
J Neuroimmunol; 1994 Jan; 49(1-2):145-52. PubMed ID: 8294552
[TBL] [Abstract][Full Text] [Related]
2. CD59 homologue regulates complement-dependent cytolysis of rat Schwann cells.
Sawant-Mane S; Piddlesden SJ; Morgan BP; Holers VM; Koski CL
J Neuroimmunol; 1996 Sep; 69(1-2):63-71. PubMed ID: 8823377
[TBL] [Abstract][Full Text] [Related]
3. In vitro demyelination by serum antibody from patients with Guillain-Barré syndrome requires terminal complement complexes.
Sawant-Mane S; Clark MB; Koski CL
Ann Neurol; 1991 Apr; 29(4):397-404. PubMed ID: 1718212
[TBL] [Abstract][Full Text] [Related]
4. Effects of Guillain-Barré sera containing antibodies against glycolipids in cultures of rat Schwann cells and sensory neurons.
Mithen FA; Ilyas AA; Birchem R; Cook SD
J Neurol Sci; 1992 Oct; 112(1-2):223-32. PubMed ID: 1469435
[TBL] [Abstract][Full Text] [Related]
5. Serum-mediated Schwann cell cytotoxicity in the Guillain-Barré syndrome.
Lisak RP; Kuchmy D; Armati-Gulson PJ; Brown MJ; Sumner AJ
Neurology; 1984 Sep; 34(9):1240-3. PubMed ID: 6540410
[TBL] [Abstract][Full Text] [Related]
6. Characterization of complement-fixing antibodies to peripheral nerve myelin in Guillain-Barré syndrome.
Koski CL
Ann Neurol; 1990; 27 Suppl():S44-7. PubMed ID: 2194426
[TBL] [Abstract][Full Text] [Related]
7. Complement-dependent lysis of tumor cells by a baboon IgM antibody to a tumor-associated antigen.
Hunt KK; Shibata M; Gupta RK; Morton DL
Cancer Immunol Immunother; 1992; 34(6):377-82. PubMed ID: 1563014
[TBL] [Abstract][Full Text] [Related]
8. Anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen.
Koski CL; Chou DK; Jungalwala FB
J Clin Invest; 1989 Jul; 84(1):280-7. PubMed ID: 2738153
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Schwann cell damage in inflammatory neuropathy.
Koski CL
J Infect Dis; 1997 Dec; 176 Suppl 2():S169-72. PubMed ID: 9396705
[TBL] [Abstract][Full Text] [Related]
10. Demyelination in vivo by Guillain-Barré syndrome and other human serum.
Brown MJ; Rosen JL; Lisak RP
Muscle Nerve; 1987; 10(3):263-71. PubMed ID: 3561445
[TBL] [Abstract][Full Text] [Related]
11. Immunologic studies of rabies vaccination-induced Guillain-Barré syndrome.
Hemachudha T; Griffin DE; Chen WW; Johnson RT
Neurology; 1988 Mar; 38(3):375-8. PubMed ID: 2450302
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
Schlager SI; Ohanian SH; Borsos T
Cancer Res; 1976 Oct; 36(10):3672-7. PubMed ID: 182362
[TBL] [Abstract][Full Text] [Related]
13. Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies.
Koski CL; Sanders ME; Swoveland PT; Lawley TJ; Shin ML; Frank MM; Joiner KA
J Clin Invest; 1987 Nov; 80(5):1492-7. PubMed ID: 3680509
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural effects of Guillain-Barré serum in cultures containing only rat Schwann cells and dorsal root ganglion neurons.
Birchem R; Mithen FA; L'Empereur KM; Wessels MM
Brain Res; 1987 Sep; 421(1-2):173-85. PubMed ID: 3690267
[TBL] [Abstract][Full Text] [Related]
15. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy.
Hafer-Macko CE; Sheikh KA; Li CY; Ho TW; Cornblath DR; McKhann GM; Asbury AK; Griffin JW
Ann Neurol; 1996 May; 39(5):625-35. PubMed ID: 8619548
[TBL] [Abstract][Full Text] [Related]
16. Abnormal serum factors in Guillain-Barré syndrome.
Lisak RP; Brown MJ; Summer AJ
Ital J Neurol Sci; 1983 Sep; 4(3):265-72. PubMed ID: 6358121
[TBL] [Abstract][Full Text] [Related]
17. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
[TBL] [Abstract][Full Text] [Related]
18. Effects of A23187 in cultures containing only rat Schwann cells and sensory neurons.
Mithen FA; Birchem R
Brain Res; 1990 Aug; 525(2):267-74. PubMed ID: 2123728
[TBL] [Abstract][Full Text] [Related]
19. Porcine islet cells of Langerhans are destroyed by human complement and not by antibody-dependent cell-mediated mechanisms.
Schaapherder AF; Wolvekamp MC; te Bulte MT; Bouwman E; Gooszen HG; Daha MR
Transplantation; 1996 Jul; 62(1):29-33. PubMed ID: 8693539
[TBL] [Abstract][Full Text] [Related]
20. Complement-mediated anti-HIV-1 effect induced by human IgM monoclonal antibody against ganglioside GM2.
Wu X; Okada N; Momota H; Irie RF; Okada H
J Immunol; 1999 Jan; 162(1):533-9. PubMed ID: 9886430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
